-
Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.
The risks associated with various levels of serum cholesterol were determined by analysis of 6-year mortality in 361,662 men aged 35-57. Above the 20th percentile for serum cholesterol (greater than 181 mg/dl, greater than 4.68 mmol/l), coronary heart disease (CHD) mortality increased progressively; the relative risk was large (3.8) in the men with cholesterol levels above the 85th percentile (greater than 253 mg/dl, greater than 6.54 mmol/l). When men below the 20th cholesterol percentile were used as the baseline risk group, half of all CHD deaths were associated with raised serum cholesterol concentrations; half of these excess deaths were in men with cholesterol levels above the 85th percentile. For both CHD and total mortality, serum cholesterol was similar to diastolic blood pressure in the shape of the risk curve and in the size of the high-risk group. This new evidence supports the policy of a moderate fat intake for the general population and intensive treatment for those at high risk. There is a striking analogy between serum cholesterol and blood pressure in the epidemiological basis for identifying a large segment of the population (10-15%) for intensive treatment.
PMID: 2877128 [PubMed - indexed for MEDLINE]
-
Cited by 56 PubMed Central articles
-
Correlation between myocardial enzyme serum levels and markers of inflammation with severity of coronary artery disease and Gensini score: a hospital-based, prospective study in Greek patients.
Peppes V, Rammos G, Manios E, Koroboki E, Rokas S, Zakopoulos N.
Clin Interv Aging. 2008; 3(4):699-710.
[Clin Interv Aging. 2008]
-
Effect of the 3'APOB-VNTR polymorphism on the lipid profiles in the Guangxi Hei Yi Zhuang and Han populations.
Ruixing Y, Guangqin C, Yong W, Weixiong L, Dezhai Y, Shangling P.
BMC Med Genet. 2007 Jul 17; 8:45. Epub 2007 Jul 17.
[BMC Med Genet. 2007]
-
ReviewLower is better: implications of the Treating to New Targets (TNT) study for Canadian patients.
Fitchett DH, Leiter LA, Goodman SG, Langer A.
Can J Cardiol. 2006 Aug; 22(10):835-9.
[Can J Cardiol. 2006]
- » See all...